Showing 8311-8320 of 10736 results for "".
Psoriasis Update 2025: Dr. Gelfand
https://practicaldermatology.com/programs/practical-dermatology/psoriasis-update-2025-dr-gelfand/32672/Joel Gelfand, MD, MSCE, discusses highlights from the "Psoriasis Update 2025" panel at Maui Derm 2025, including the potential for combining TNF inhibitors with IL-23 inhibitors; home phototherapy; and the possibility of GLP-1 agonists lowering the severity of psoriatic disease.ASDS: Dr. Green on the Annual Meeting
https://practicaldermatology.com/conferences/asds-2024-annual-meeting/asds-dr-green-annual-meeting/29169/Lawrence Green, MD, FAAD, talks about the education and networking that make the American Society for Dermatologic Surgery Annual Meeting special.Innovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.Expanded Indications for UltraClear Cold Ablative Fractional Fiber Laser
https://practicaldermatology.com/series/c-suite-chats/expanded-indications-ultraclear-cold-ablative-fractional-fiber-laser/26268/Shlomo Assa, President and Co-Founder of Acclaro Medical, discusses the versatility of the UltraClear Cold Ablative Fractional Fiber Laser, which recently received FDA clearance to treat benign pigmented lesions and vascular dyschromia.Current Unmet Needs in Plaque Psoriasis
https://practicaldermatology.com/topics/psoriasis/current-unmet-needs-in-plaque-psoriasis/20098/Patrick Burnett, Chief Medical Officer of Arcutis Biotherapeutics, discusses new insights from a national survey on the psychosocial impact of plaque psoriasis and the current unmet need for topical therapies for plaque psoriasis. These data reinforce that psychosocial wellbeing can be just as imporMeaningful Innovation in Medical Dermatology at Arcutis Biotherapeutics
https://practicaldermatology.com/topics/psoriasis/meaningful-innovation-in-medical-dermatology-at-arcutis-biotherapeutics/20099/Frank Watanabe, President and CEO of Arcutis Biotherapeutics, shares what “meaningful innovation” means to Arcutis and how the company aims to create meaningful change for people living with chronic skin conditions.Liquid Rhinoplasty and Beyond: Injectable Pearls
https://practicaldermatology.com/videos/scientifically-speaking/liquid-rhinoplasty-and-beyond-injectable-pearls/20008/From the best approach to safe and effective liquid nose corrections to tips for enhancing outcomes and streamline operations, Michael Somenek, MD; Kay Durairaj, MD; Shino Bay Aguilera, DO; and Corey Hartman, MD share their best tips with host Joel L. Cohen, MD.Get Ready for JAK Inhibitors
https://practicaldermatology.com/topics/psoriasis/get-ready-for-jak-inhibitors/19928/JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.Does Diet Matter in Management of Psoriasis?
https://practicaldermatology.com/topics/psoriasis/does-diet-matter-in-management-of-psoriasis/19653/Ronald Prussick, MD says there are dietary changes patients with psoriasis can make to potentially help manage their disease and lower their BMI, which can help improve psoriasis symptoms. He shares some tips and discusses when a referral to a registered dietician makes sense.Depression and Psoriasis: What’s the Link?
https://practicaldermatology.com/topics/psoriasis/depression-and-psoriasis-whats-the-link/19652/Can depression lead to psoriasis or are psoriasis patients at an increased risk for depression? Ronald Prussick, MD talks about the link and what you and your patients should know.